ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,824Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 783

$1.16M Total Retail Price of All Prescriptions

Rank: 30 out of 783

568 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 568 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 568 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 15,885 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
FUROSEMIDE 758 640 1 7
LEVOTHYROXINE SODIUM 653 583 2 1
WARFARIN SODIUM 595 524 3 10
LISINOPRIL 594 534 4 4
OMEPRAZOLE 586 468 5 6
HYDROCODONE-ACETAMINOPHEN 527 301 S3 6 2
SIMVASTATIN 523 426 7 3
METFORMIN HCL 369 294 8 8
AMLODIPINE BESYLATE 353 305 9 5
KLOR-CON M20 300 249 10 48
POTASSIUM CHLORIDE 299 263 11 16
GABAPENTIN 293 188 12 15
ATENOLOL 282 278 13 17
DIGOXIN 277 260 14 61
ATORVASTATIN CALCIUM 272 207 15 11
FENOFIBRATE 271 197 16 66
METOPROLOL TARTRATE 260 232 17 9
NAMENDA 257 253 18 32
PRAVASTATIN SODIUM 235 181 19 14
DONEPEZIL HCL 225 218 20 24
MIRTAZAPINE 223 183 21 52
TRAMADOL HCL 218 165 22 20
ALENDRONATE SODIUM 217 179 23 25
CLOPIDOGREL 187 171 24 29
GLIMEPIRIDE 181 169 25 34
PANTOPRAZOLE SODIUM 179 155 26 30
SPIRONOLACTONE 172 124 27 57
ZOLPIDEM TARTRATE 167 130 28 23
TRILIPIX 166 111 29 192
SERTRALINE HCL 159 115 30 22
SPIRIVA 157 111 31 59
FAMOTIDINE 157 111 31 55
CRESTOR 153 110 33 27
HYDROCHLOROTHIAZIDE 146 135 34 12
ADVAIR DISKUS 144 119 35 50
RISPERIDONE 139 125 36 67
CARVEDILOL 135 118 37 21
METOPROLOL SUCCINATE 133 117 38 13
MELOXICAM 133 118 38 37
KLOR-CON M10 133 113 38 137
CITALOPRAM HBR 131 104 41 19
PLAVIX 125 122 42 51
FENTANYL 112 72 S2 43 65
DIVALPROEX SODIUM 110 87 44 72
TAMSULOSIN HCL 109 96 45 26
LOSARTAN POTASSIUM 107 104 46 18
CARBIDOPA-LEVODOPA 106 85 47 88
AMITRIPTYLINE HCL 99 53 R 48 77
NIASPAN 97 75 49 140
ALLOPURINOL 93 77 50 31
LANTUS 89 63 51 38
LEVOFLOXACIN 89 70 51 75
ALBUTEROL SULFATE 86 84 53 136
PREDNISONE 86 63 53 36
ISOSORBIDE MONONITRATE ER 84 84 55 40
DIOVAN 84 75 55 49
CEPHALEXIN 83 67 57 70
AZITHROMYCIN 83 66 57 41
CYCLOBENZAPRINE HCL 83 28 R 57 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 58 60 33
GENERLAC 80 76 61 246
LYRICA 80 68 61 98
VENLAFAXINE HCL ER 78 54 63 100
NEXIUM 75 50 64 28
CLARITHROMYCIN 75 60 64 385
LOVASTATIN 73 71 66 58
NYSTATIN 72 69 67 106
PROAIR HFA 72 21 67 56
NYSTATIN-TRIAMCINOLONE 71 70 69 317
TRIAMTERENE-HCTZ 70 57 70 42
CLONIDINE HCL 69 69 71 60
OXYBUTYNIN CHLORIDE ER 69 69 71 117
LOSARTAN-HYDROCHLOROTHIAZIDE 68 65 73 53
NAPROXEN 68 48 73 104
TRICOR 68 37 73 134
ESCITALOPRAM OXALATE 66 36 76 54
CIPROFLOXACIN HCL 65 57 77 62
VERAPAMIL ER 62 50 78 119
FLUOXETINE HCL 62 51 78 45
GEMFIBROZIL 62 40 78 105
ROPINIROLE HCL 61 48 81 74
JANUVIA 60 48 82 73
AMLODIPINE BESYLATE-BENAZEPRIL 59 59 83 83
DILTIAZEM 24HR CD 59 59 83 118
CYMBALTA 59 25 83 35
ZIPRASIDONE HCL 59 59 83 314
ZETIA 58 41 87 80
NABUMETONE 56 22 88 178
PROPRANOLOL HCL 55 28 89 129
DIOVAN HCT 55 44 89 94
LOVAZA 55 50 89 163
TRAVATAN Z 54 49 92 268
FLUTICASONE PROPIONATE 54 15 92 46
PHENYTOIN SODIUM EXTENDED 54 33 92 141
RANITIDINE HCL 54 37 92 44
LAMOTRIGINE 53 22 96 156
BYSTOLIC 52 52 97 99
QUETIAPINE FUMARATE 51 32 98 79
PENTOXIFYLLINE 51 30 98 293
NOVOLOG 51 51 98 81
OLANZAPINE 50 50 101 108
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.